Alzamend Neuro Sues Contract Research Firm Biorasi in Federal Court

Alzamend Neuro, Inc. sued Biorasi, LLC in case number 25-cv-20481, and the court issued an order on April 19, 2026. Beyond that, the public record is thin. No judge has been assigned on the face of the docket, the filing date is not confirmed, and the key issues have not been disclosed in available filings.

Alzamend Neuro is a clinical-stage biopharmaceutical company focused on Alzheimer's treatments. Biorasi is a contract research organization that runs clinical trials. The dispute likely touches their working relationship, but no complaint text or cause of action is confirmed in the current record.

The April 19 order is the only docketed event in the timeline. Whether it is a scheduling order, a discovery ruling, or something more consequential is not yet clear from available information. Until the order's substance surfaces, its effect on the case cannot be assessed.

This explainer will sharpen as filings become available. Right now the docket is a placeholder, not a story.